Ignite Creation Date:
2024-07-17 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06487052
Status:
RECRUITING
Last Update Posted:
2024-07-05
First Post:
2024-06-27
Brief Title:
Evaluation of the Standard Catheter-directed Thrombolysis Effectiveness in Intermediate-High-Risk Pulmonary Embolism Patients
Sponsor:
Federal State Budgetary Institution V A Almazov Federal North-West Medical Research Centre of the Ministry of Health
Organization:
Federal State Budgetary Institution V A Almazov Federal North-West Medical Research Centre of the Ministry of Health
Study Overview
Official Title:
Evaluation of the Standard Catheter-directed Thrombolysis SCDT Effectiveness in Intermediate-High-Risk Pulmonary Embolism Patients
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ESCADlys-PE
Brief Summary:
A single-center open-label randomized comparative study of two treatment strategies in patients with intermediate-high-risk acute pulmonary embolism PE Patients will be randomized in a 11 ratio to standard anticoagulant therapy or standard catheter-directed thrombolysis SСDT with a low dose of alteplase followed by evaluation of short- and long-term efficacy and safety in each group
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None